Markman Advisors
Patent Valuation, Monetization and Investments

Blog

Markman Advisors Patent Blog

by Zachary Silbersher

Posts tagged AD26.COV2-S
Which patents cover the COVID-19 vaccine candidates for Moderna, AstraZeneca, J&J and Novovax?

A number of companies have announced candidates for a COVID-19 vaccine, including Moderna Therapeutics ($MRNA), AstraZeneca ($AZN), Johnson & Johnson ($JNJ) and Novovax ($NVAX). We looked into the existing landscape of patents that cover many of the existing candidates.

Read More
Markman AdvisorsCOVID-19, COVID, coronavirus, Moderna Therapeutics, Moderna, MRNA, $MRNA, AstraZeneca, $AZN, Johnson & Johnson, Janssen, $JNJ, Novovax, $NVAX, NVAX, patent, vaccine, betacoronavirus, mRNA, AZD1222, ChAdOx1, mRNA-1273, Oxford, adenoviral, AD26.COV2-S, NVX-CoV2373, MERS, Zachary Silbersher, SilbersherComment